-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Enlivex Therapeutics (ENLV)
-
-
-
-
-
-
-
Enlivex to Present at Upcoming Investor and Media Conferences
-
-
-
-
-
-
-
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
-
-
-
-
-
-
-
Enlivex to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference
-
-
-
-
-
-
-
Enlivex Therapeutics Announces $16.75 Million Registered Direct Offering
-
-
-
-
-
-
-
Enlivex Therapeutics To Present At The 21st Annual Global Investment Conference, Sponsored By H.C. Wainwright & Co.
-
-
-
20,596 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

